Glanbia Plc

Glanbia Plc

108.40
USD
-8.60
(-7.35%)
Glanbia Plc
OTC:GLAPY
(OTC Markets)

Recent

price

108.40

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
USD
50.16
42.67
49.74
54.79
48.55
50.87
39,761.52
48.54
61.44
72.4
78.59
81.91
107.77
101.77
73.68
78.76
Revenue per Share
2.5
2.48
3.26
3.46
2.8
3.36
3,773.58
6.7
4.53
3.37
2.96
3.26
4.92
6.46
3.16
3.66
Basic EPS, GAAP
0.78
1.46
0.07
0.03
1.15
2.81
4,156.63
0.38
4.12
2.54
4.38
3.39
4.38
6.63
6.83
5.66
Free Cash Flow per Basic Share
0.47
0.51
0.57
0.64
0.59
0.62
662.78
0.83
1.47
1.39
1.62
1.57
1.61
1.82
2
2.35
Dividend per Share
1.93
2.27
2.41
2.92
3.04
3.86
4.32
5.6
6.14
6.34
6.64
6.83
7.33
8.12
8.08
7.95
Book Value per Share
0.28
0.21
0.29
0.83
0.51
0.38
0.89
1.71
1.1
1.33
1.52
1.41
1.61
2.27
1.81
1.62
Tangible Book Value per Share
59
59
59
59
59
59
- -
59
59
59
59
58
55
53
52
50
Basic Weighted Avg Shares
2,940
2,505
2,925
3,229
2,865
3,003
2,347
2,864
3,627
4,275
4,640
4,752
5,944
5,425
3,840
3,946
Sales/Revenue/Turnover
6.6
6.33
7.21
7.03
7.3
7.7
9.93
9.25
7.54
4.61
3.11
3.79
3.98
7.18
6.09
6.95
Operating Margin (%)
65
53
59
65
62
80
95
135
102
120
151
144
150
149
156
149
Depreciation Expense
147
145
192
204
165
198
223
395
268
199
175
189
271
344
165
183
Net Income, GAAP
19.36
20.43
16.09
14.21
15.2
15.9
16.47
- -
12.29
9.49
7.86
10.76
11.42
11.39
20.82
12.38
Effective Tax Rate (%)
4.99
5.8
6.55
6.31
5.76
6.61
9.49
13.8
7.38
4.65
3.76
3.98
4.57
6.35
4.29
4.64
Profit Margin (%)
524
512
438
361
379
413
382
482
516
240
174
613
461
603
433
434
Working Capital
777
772
645
599
700
815
656
599
861
567
671
909
786
643
637
730
LT Debt
576
678
720
872
908
1,151
1,291
1,658
1,818
1,877
1,956
1,971
1,993
2,133
2,073
1,927
Total Equity
12.46
8.79
11.77
13.19
11.59
10.66
9.56
- -
9.31
6.24
4.49
5.22
6.63
11.14
6.01
7.65
Return on Invested Capital (%)
12.82
11.97
14.39
15.62
11.89
11.92
12.12
- -
11.42
8.24
6.97
6.94
9.48
12.09
6.33
6.87
Return on Capital (%)
30.22
23.54
27.8
25.92
18.75
19.44
18.41
26.92
15.4
10.76
9.11
9.65
13.76
16.73
7.83
9.16
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

USD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.68%
-0.19%
-7.02%
Free Cash Flow
100.61%
5.12%
-20.33%
Net Income, GAAP
5.74%
7.58%
11.29%
Sales/Revenue/Turnover
4.55%
-1.53%
2.78%
Total Cash Common Dividend
14.24%
4.54%
12.84%

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
3,840
2025
- -
- -
- -
- -
3,946
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
3.16
2025
- -
- -
- -
- -
3.66
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
2
2025
- -
- -
- -
- -
2.35
2026
- -
- -
- -
- -
- -

Company News

  • Glanbia plc (GLAPY) Q2 2026 Earnings Call Transcript

  • Glanbia hikes profit forecast as weight-loss drugs boost demand for protein products

  • Glanbia Stock More Than Doubles as Protein Demand May Rise 37%

  • Is Glanbia (GLAPY) Stock Outpacing Its Consumer Staples Peers This Year?

  • Longleaf Partners Global Fund Q1 2026 Portfolio Review

  • Glanbia plc (GLAPY) Q4 2025 Earnings Call Transcript

  • Glanbia plc (GLAPY) Analyst/Investor Day Transcript

  • Glanbia plc (GLAPY) Q3 2025 Earnings Call Transcript

  • Longleaf Partners Global Fund Q3 2025 Notable Contributors & Detractors

  • Head to Head Survey: Glanbia (OTCMKTS:GLAPY) vs. China Mengniu Dairy (OTCMKTS:CIADY)

  • Glanbia to sell Slimfast US to Heartland Food Products group of US

  • Glanbia plc (GLAPF) Q2 2025 Earnings Call Transcript

  • Flax Protein Markets and Companies Analysis Report 2025 with Forecasts to 2029 & 2034 - Featuring Glanbia Nutritionals, Grain Millers, Myprotein, Linwoods Health Foods, Bioriginal Food & Science Corp. and More

  • Glanbia shares jump after 'better than feared' first quarter

  • Glanbia plc (GLAPF) 2024 Full Year Results Earnings Call Transcript

  • Supplements producer Glanbia's shares dive on profit warning

  • Glanbia plc (GLAPF) Q4 2023 Earnings Call Transcript

  • Glanbia: Fairly Valued For Current Performance

  • Glanbia plc (GLAPF) Q2 2023 Earnings Call Transcript

  • Glanbia plc (GLAPF) Q4 2022 Earnings Call Transcript